SIGYN THERAPEUTICS, INC. (SIGY) Gross margin 2014–2019
SIGYN THERAPEUTICS, INC. (SIGY) gross margin by fiscal year — reported gross profit divided by reported revenue.
75.1%FY2019 · since FY2014: 41.5% → 75.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 75.1% | +9.4 pp |
| FY2018 | 65.7% | +21.5 pp |
| FY2017 | 44.2% | — |
| FY2015 | 66.0% | +24.5 pp |
| FY2014 | 41.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice